Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.

Dieter Kunz Yves DauvilliersHeike BenesDiego García-BorregueroGiuseppe PlazziDalma Seboek KinterPreciosa ColomaMagdalene RauschMouna Sassi-SayadiStephen Thein

Published in: CNS drugs (2022)

ClinicalTrials.gov (NCT03679884) [first posted: 21 September, 2018], https://clinicaltrials.gov/ct2/show/NCT03679884 .

Keyphrases

image quality
open label
computed tomography
dual energy
contrast enhanced
sleep quality
double blind
randomized controlled trial
clinical trial
depressive symptoms
placebo controlled
study protocol